Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease.
about
Rotenone, paraquat, and Parkinson's diseaseNeurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson's diseaseEnvironmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in miceEnteric neurons from Parkinson's disease patients display ex vivo aberrations in mitochondrial structure.Neuron-selective changes in RNA transcripts related to energy metabolism in toxic models of parkinsonism in rodents.Neurochemical phenotypes of myenteric neurons in the rhesus monkey.Differential regional and subtype-specific vulnerability of enteric neurons to mitochondrial dysfunction.Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease.The management of gastrointestinal symptoms in Parkinson's disease.Exploring Braak's Hypothesis of Parkinson's Disease.Aging and gastrointestinal neuromuscular function: insights from within and outside the gut.Unexpected improvements of spatial learning and memory abilities in chronic rotenone intoxicated mice.Gastrointestinal dysfunction in a Parkinson's disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus.α-Synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficitsAnimal models of the non-motor features of Parkinson's disease.Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss.Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation.Rotenone-induced energy stress decompensated in ventral mesocerebrum is associated with Parkinsonism progression in ratsEnteric nervous system in the small intestine: pathophysiology and clinical implications.Restoration of intestinal function in an MPTP model of Parkinson's Disease.Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments.Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models.Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.Animal models of Parkinson's disease: a gateway to therapeutics?Neuropathobiology of non-motor symptoms in Parkinson disease.RNA-Seq Expression Analysis of Enteric Neuron Cells with Rotenone Treatment and Prediction of Regulated Pathways.Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models.Involvement of catecholaminergic neurons in motor innervation of striated muscle in the mouse esophagus.The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6-hydroxydopamine microinjection in the substantia nigra.New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's diseaseBeneficial Effect of Vitamin E in Rotenone Induced Model of PD: Behavioural, Neurochemical and Biochemical Study.Neuroprotective effects of metallothionein against rotenone-induced myenteric neurodegeneration in parkinsonian mice.Effects of oral administration of rotenone on gastrointestinal functions in mice.Rotenone and elevated extracellular potassium concentration induce cell-specific fibrillation of α-synuclein in axons of cholinergic enteric neurons in the guinea-pig ileum.Ameliorative Effect of Quercetin on Neurochemical and Behavioral Deficits in Rotenone Rat Model of Parkinson's Disease: Modulating Autophagy (Quercetin on Experimental Parkinson's Disease).Enteric nervous system manifestations of neurodegenerative disease.Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson's Disease.Long-Term Systemic Exposure to Rotenone Induces Central and Peripheral Pathology of Parkinson's Disease in Mice.Gut-brain and brain-gut axis in Parkinson's disease models: Effects of a uridine and fish oil diet.Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's disease.
P2860
Q22241595-9ADA1BB2-88D2-4ABE-8DD8-76E5BC5438D2Q27012533-3FB8FBDF-63D3-4302-84A9-F7D2267DA159Q30528818-F9215334-728F-4F31-B000-A4D4D2749D02Q30810965-C1840E7F-88D4-4F6D-AD49-DD021E2F0606Q33544048-F3DE2D77-CACB-40DD-A0C9-4E7231A0EDE2Q33660885-3AF6C23A-0E09-4461-B2ED-7557BFE9EDA3Q34081771-6AA87D82-CCAF-4517-B14E-96AB51984795Q34092416-3886EFF1-6E2B-4928-A3BE-FE7C15C1CB9EQ34250597-5C22D0C9-EDBD-46F8-97FA-C5549FA90658Q34552244-F29ED42C-8F39-40AF-9B3B-9E36E80DEC0DQ34981170-554867C6-9108-4674-81CD-F5443E5834C8Q35117486-ADECF590-3AB5-4E6B-A45E-D7AF27FA9F00Q35917625-D456247D-0B24-4494-9173-6B959B542A2FQ36034871-CC1A79AE-88E9-4CCD-BE4C-7CA5B27B65D6Q36235578-3C9C46D7-F692-4453-8CA6-299EFAAAD1C9Q36323014-4AB8CA09-C853-4744-8C66-157C57E0EC21Q37016812-9B1B2F6C-C833-4765-A27F-D71FE585DE94Q37108659-9532B855-25E5-4AF0-A161-9EFF9923D960Q37118938-8769D0F4-2378-414C-959A-830B9A81542EQ37137476-C4D412A2-A409-4F51-BA17-123AEC3AAEEEQ37516494-093CE1BB-0D05-4343-81D0-306E373069DDQ38009051-33E93810-684E-46C5-A113-0E68DEF09FCFQ38074802-F7CA597A-2DE0-4896-B9D8-4C66908D7E9EQ38155480-AC118294-8964-457A-BF0F-CB70C945F667Q38481481-AE7A30DE-01DB-4245-9065-296AAA850459Q38789145-D6D56CE4-0B1D-4A1E-A75D-DCF908E6AC02Q38950077-6324441B-BA70-4A2C-8D1B-8615D1F64218Q40078793-409A58F4-094B-4352-8405-A6AFD579ED27Q40163139-395848F1-066E-4DEA-8D21-D70695EA4525Q41876470-917BFF6C-5BBB-4672-9224-57460FF51870Q41884130-8B8630B4-B412-4645-8393-6AF048C6E105Q42460533-7396914D-7C09-4C1E-B025-5BFB926369C2Q43677832-75FD0597-26D3-4568-849D-BFB21A801E35Q46217157-8E3EFA5F-0155-4121-8A1E-C048743B621FQ46507149-20B4191A-72FF-44DC-B025-801FACF8BD0FQ47845191-C2CE95F4-69EA-4924-AEB2-49E05AD2D27DQ47845984-2C446450-1638-41D1-889F-B22BF943A1A6Q48219808-2E9D3B68-8022-4D4C-BF93-2919559D5A46Q48271913-9AC5ED44-1F86-4289-B07E-BAA18B37A35EQ52148501-C7779984-DD3C-4A0D-A6D5-6D5323E13C01
P2860
Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Delayed gastric emptying and e ...... model of Parkinson's disease.
@en
type
label
Delayed gastric emptying and e ...... model of Parkinson's disease.
@en
prefLabel
Delayed gastric emptying and e ...... model of Parkinson's disease.
@en
P2093
P2860
P1476
Delayed gastric emptying and e ...... model of Parkinson's disease.
@en
P2093
Ali Reza Noorian
James G Greene
Shanthi Srinivasan
P2860
P304
P356
10.1016/J.EXPNEUROL.2009.04.023
P407
P577
2009-05-03T00:00:00Z